Low Dose Naltrexone (LDN) is a drug that helps regulate a dysfunctional immune system in autoimmune diseases such as Cancers, HIV/Aids, Fibromyalgia, MS, Crohn’s etc. LDN is non toxic and can be prescribed “off label” on the NHS.
We strive to make LDN a first line treatment available for all on the NHS.

Bookmark and Share
My Charity Page Start Fundraising
Newsletter Signup

Email:


Enter the numbers
into box below



LDN Research Trust Survey

If you have MS and ANY of the following descriptions applies to you, we would be grateful if you could spare a few minutes of your time to take part in this survey: -

  • you are currently taking LDN, and have been doing so for at least four months
  • you have taken LDN in the past but are no longer taking it
  • you took part in our first survey

In addition, we hope that all participants will be willing to complete this survey every six months, enabling us to effectively track the progress of a large number of LDN users.

The survey results will be presented to the medical profession, research and funding bodies, posted on the internet and printed wherever possible.

Please note - all personal details are kept private and confidential.
Survey participants will remain anonymous in all presentations of the survey results.

 

Click here to access the survey area

Website by LWR Online : Website Design, Website Hosting & CMS System